Dechra Acquires Veterinary Products Isoflurane and Sevoflurane
Dechra has acquired veterinary inhalant anesthetic products Isoflurane and Sevoflurane from Halocarbon.

Dechra has acquired veterinary inhalant anesthetic products Isoflurane and Sevoflurane from Halocarbon. Getty Images

Dechra is pleased to announce the acquisition of the veterinary approved Isoflurane®, USP Inhalant Anesthetic and Sevoflurane®, USP Inhalant Anesthetic from Halocarbon.

Mike Eldred, President of Dechra North America, stated, “These products are utilized daily in veterinary hospitals and complement our current sedative and anesthetic product range. We are excited to continue to grow and expand our veterinary surgical suite and anesthetic portfolio and offer high quality products to the veterinary community.”

Dechra will be launching the veterinary branded Isoflurane and Sevoflurane in the first quarter of 2022.

About Dechra:

Dechra’s companion animal portfolio focuses on endocrinology, dermatology, ophthalmology, anesthesia, fluid therapy, pain management, joint health support, and dental care. Our brands include Vetoryl® Capsules (trilostane), Zycortal® Suspension (desoxycorticosterone pivalate injectable suspension), Felimazole® Coated Tablets (methimazole), the Vetivex® line of parenteral fluids, and Phycox® joint health supplements. Osurnia® (florfenicol, terbinafine, betamethasone acetate) and the TrizUltra+Keto®, MiconaHex+Triz®, MalAcetic®, and oral anti-infective product lines, including Marboquin® (marbofloxacin) Tablets and Amoxicillin and Clavulanate Potassium for Oral Suspension, spotlight the dermatology offerings. And the recent addition of Mirataz® (mirtazapine transdermal ointment), Porus® One, and Redonyl® Ultra Feline to the portfolio supports the underserved feline market. 

Trending Articles
Ontario Broodmare Positive for EHV-1
Horse and woman in winter
Veterinary Wellness Briefs: Tips for Staying Warm as an Ambulatory Practitioner 
Vet In Discussion With Horse Owner
The Business of Practice: Emergency-Only Practices
New Collaboration Between Boehringer Ingelheim and Sleip Leverages AI Technology to Help Detect Lameness in Horses

"*" indicates required fields

Get the best from EquiManagement delivered straight to your inbox once a week! Topics include horse care, disease alerts, and vet practitioner updates.

Additional Offers

This field is for validation purposes and should be left unchanged.